The American Heart Association (AHA) has issued new guidelines for preventing heart disease and stroke in women based on their risk level. It is the first time that "evidence-based" recommendations are being made. Despite the fact that nearly every minute a woman in the United States dies of cardiovascular disease, not many women consider it their greatest health risk. The guidelines are based on analysis of medical literature and scientific studies and were written by experts from the AHA and other professional and governmental organizations. Overall, the guidelines suggest that all women follow a heart-healthy diet, maintain a healthy weight, exercise for at least 30 minutes most days of the week, and not smoke. More specifically, the guidelines recommend the following:
Other recommendations were made that depend on a woman's health status. For example, daily aspirin is recommended for high-risk women, but not for low-risk women. For intermediate- risk women, aspirin therapy should be considered only if their blood pressure is under control and their physician decides that the risk?benefit ratio is in their favor.Women at any risk level, however, should not take hormone replacement therapy or antioxidant vitamin supplements, according to these guidelines.
Get to know RESPIMAT, the slow-moving mist inhaler from Boehringer Ingelheim Pharmaceuticals, Inc.
Watch the RESPIMAT video and test your knowledge with a short multiple-choice quiz. When you get all the answers right, you’ll receive a certificate naming you a RESPIMAT T.O.P. Performer. Why not check it out today?
Clinical features with downloadable PDFs